CISATRACURIUM BESYLATE and CARDIAC ARREST

82 reports of this reaction

2.2% of all CISATRACURIUM BESYLATE reports

#9 most reported adverse reaction

Overview

CARDIAC ARREST is the #9 most commonly reported adverse reaction for CISATRACURIUM BESYLATE, manufactured by Fresenius Kabi USA, LLC. There are 82 FDA adverse event reports linking CISATRACURIUM BESYLATE to CARDIAC ARREST. This represents approximately 2.2% of all 3,661 adverse event reports for this drug.

Patients taking CISATRACURIUM BESYLATE who experience cardiac arrest should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

CARDIAC ARREST82 of 3,661 reports

CARDIAC ARREST is a less commonly reported adverse event for CISATRACURIUM BESYLATE, but still significant enough to appear in the safety profile.

Other Side Effects of CISATRACURIUM BESYLATE

In addition to cardiac arrest, the following adverse reactions have been reported for CISATRACURIUM BESYLATE:

OFF LABEL USE — 156 reports
HYPOTENSION — 146 reports
ANAPHYLACTIC SHOCK — 116 reports
ANAESTHETIC COMPLICATION NEUROLOGICAL — 115 reports
DRUG INEFFECTIVE — 113 reports
DRUG INTERACTION — 113 reports
ANAPHYLACTIC REACTION — 112 reports
RHABDOMYOLYSIS — 83 reports
ACUTE KIDNEY INJURY — 74 reports
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS — 72 reports

Other Drugs Associated with CARDIAC ARREST

The following drugs have also been linked to cardiac arrest in FDA adverse event reports:

ACETAMINOPHEN AND PHENYLEPHRINE HYDROCHLORIDE ADENOSINE AIR ALCOHOL AMPHETAMINE AMPHETAMINE SULFATE ARTICAINE HYDROCHLORIDE AND EPINEPHRINE ATROPINE ATROPINE SULFATE BIVALIRUDIN CARBON DIOXIDE CEFAZOLIN CEFAZOLIN SODIUM CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HBR DERMA FOAM EXCEL HAND SANITIZER DEXTROMETHORPHAN HBR DEXTROMETHORPHAN HBR AND GUAIFENESIN DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE DIPHENHYDRAMINE HCL DOPAMINE HYDROCHLORIDE

Frequently Asked Questions

Does CISATRACURIUM BESYLATE cause CARDIAC ARREST?

CARDIAC ARREST has been reported as an adverse event in 82 FDA reports for CISATRACURIUM BESYLATE. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is CARDIAC ARREST with CISATRACURIUM BESYLATE?

CARDIAC ARREST accounts for approximately 2.2% of all adverse event reports for CISATRACURIUM BESYLATE, making it a notable side effect.

What should I do if I experience CARDIAC ARREST while taking CISATRACURIUM BESYLATE?

If you experience cardiac arrest while taking CISATRACURIUM BESYLATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

CISATRACURIUM BESYLATE Full Profile All Drugs Causing CARDIAC ARREST Fresenius Kabi USA, LLC Drugs

Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.